Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study

BACKGROUND: Levodopa‐carbidopa intestinal gel (LCIG) is administered directly to the small intestine of patients with advanced Parkinson's disease (APD) to help maintain stable plasma levodopa levels. OBJECTIVE: The objective of this study was to investigate the effect of LCIG in reducing polyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasano, Alfonso, Gurevich, Tanya, Jech, Robert, Kovács, Norbert, Svenningsson, Per, Szász, József, Parra, Juan Carlos, Bergmann, Lars, Johnson, Anita, Sanchez‐Soliño, Olga, Tang, Zhongwen, Vela‐Desojo, Lydia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453961/
https://www.ncbi.nlm.nih.gov/pubmed/33908647
http://dx.doi.org/10.1002/mds.28596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453961/
https://www.ncbi.nlm.nih.gov/pubmed/33908647
http://dx.doi.org/10.1002/mds.28596

Ejemplares similares